Company Overview of Inhibiton Therapeutics, Inc.
As of May 5, 2009, Inhibiton Therapeutics, Inc. was acquired by AlumiFuel Power, Inc., in a reverse merger transaction. Inhibition Therapeutics, Inc. engages in the research and development of cancer therapeutic agents and cancer fighting drugs called targeted therapies. The targeted therapies identify molecular causes of cancer and inhibit the signals that cancer cells need to multiply. The company was incorporated in 2000 and is based in Englewood, Colorado.
7315 East Peakview Avenue
Englewood, CO 80111
Founded in 2000
Key Executives for Inhibiton Therapeutics, Inc.
Inhibiton Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|iPierian, Inc.||United States|
|ActivBiotics, Inc.||United States|
|ReaMetrix, Inc.||United States|
|InterVene, Inc.||United States|
|Algos Preclinical Services, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Hyattsville, MD | University of Maryland University CollegePosted: Mar 04
- Saint Louis, MO | EnvisionPosted: Feb 13
- South San Francisco, CA | GenentechPosted: Mar 08
- San Mateo, CA |Posted: Mar 06
Sponsored Financial Commentaries
To contact Inhibiton Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.